Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

4,728 total articles

Tevogen R&D Chief Sells 972 Shares, Transactions Total About $6,635

Tevogen R&D Chief Sells 972 Shares, Transactions Total About $6,635

Neal Flomenberg, Tevogen Bio Holdings Inc.'s Chief Scientific Officer and Global R&D Lead, sold 972 shares of common stock between March 10 and March 13, 2026, for roughly $6,635. The sales were executed to cover tax obligations tied to restricted stock units. Separately, Tevogen's board is evaluating a possible one-time special cash dividend conti…

UMAC CFO Disposes $212K in Stock as Company Draws Mixed Signals

UMAC CFO Disposes $212K in Stock as Company Draws Mixed Signals

Unusual Machines CFO Brian Joseph Hoff sold 11,413 shares on March 16, 2026, generating roughly $212,163. The move comes as the stock trades near $20.91, up about 183% year-over-year, while third-party analysis flags the company as overvalued amid a recent net loss. The firm posted strong fourth-quarter revenue growth and received favorable analyst…

Upstream Bio CFO Sells Small Stake to Cover RSU Taxes; Company Progresses on Verekitug Data Presentations

Upstream Bio CFO Sells Small Stake to Cover RSU Taxes; Company Progresses on Verekitug Data Presentations

Upstream Bio CFO and COO Michael Gray sold 852 shares on March 16, 2026, for $9.29 each, totaling $7,915, to satisfy tax-withholding obligations tied to restricted stock unit vesting. The transaction occurred while the stock traded near $9.71, a level noted as above the company’s Fair Value in InvestingPro data. Upstream Bio is continuing to presen…